I'm just really worried that the failure of PI-88 in profitable indications is going to make people realise how inflated the market cap has become. PGL should now be trading much closer to cash value.
Any chance of getting to profitability now rests with their next-generation drug, but it's basically back to Phase I with nothing more than a hope and a prayer. The lung cancer failure casts grave doubt on Phase III efficacy, and the writing is on the wall. Sell.
I'm just really worried that the failure of PI-88 in profitable...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.11M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 367726 | 10 |
View Market Depth
| Last trade - 09.07am 17/07/2024 (20 minute delay) ? |
| PGL (ASX) Chart |
Day chart unavailable